|
RK Burt1, J Guitart2, A Traynor1, C Link3, S Rosen1, T Pandolfino2 & TM Kuzel1
1Northwestern University Medical Center, The Robert H Lurie Comprehensive Cancer Center, Department of Medicine, Division of Hematology Oncology, Iowa Methodist Medical Center, Des Moines, IA, USA
2Northwestern University Medical Center, Dermatology Department, Iowa Methodist Medical Center, Des Moines, IA, USA
3Human Gene Therapy Institute, Iowa Methodist Medical Center, Des Moines, IA, USA
Correspondence to: Dr R Burt, Wesley Pavilion, Room 162, Chicago, IL 60611, USA
|
Allogeneic hematopoietic stem cell transplantation should be considered as a therapeutic option for patients with generalized erythoderma or tumor stage MF. Indeed, the only curative option for MF may be an allogeneic transplant. Bone Marrow Transplantation (2000) 25, 111–113.
|
